Menarini
HCP Market Research Survey

Statin + Ezetimibe Combination: HCP Preference Survey

For cardiologists, internists and other physicians managing dyslipidaemia.

3 min 10 questions Anonymous

Question 1 of 10

Question 2 of 10

Question 3 of 10

In what percentage of your patients does statin monotherapy fail to reach the LDL-C target?

Question 4 of 10

How often do you add ezetimibe to a statin?

Question 5 of 10

If only one statin + ezetimibe combination could be launched in your country, which would you prefer?

Question 6 of 10

What are the main reasons for your preference?

Select up to 2

0 / 2 selected

Question 7 of 10

How would you rate the potential demand for a fixed-dose statin + ezetimibe combination in your practice?

Question 8 of 10

Which combination do you consider better for the following patients?

One answer per patient type

Very high CV risk / post-ACS

Diabetes

Chronic kidney disease

Elderly / polypharmacy

Statin-intolerant history

Question 9 of 10

Which format would you prefer to prescribe?

Question 10 of 10

Which strengths (statin/ezetimibe, mg) would you want available?

Select all that apply

Rosuvastatin + Ezetimibe

Atorvastatin + Ezetimibe